Literature DB >> 2302789

Dextromethorphan oxidation phenotypes as markers for susceptibility to lung cancer.

G B Faccini1, V Puchetti, N Zatti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2302789

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  2 in total

1.  The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.

Authors:  P M Christensen; P C Gøtzsche; K Brøsen
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.

Authors:  D Wu; S V Otton; B A Sproule; U Busto; T Inaba; W Kalow; E M Sellers
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.